Eton Pharmaceuticals (ETON) Change in Cash (2018 - 2025)

Eton Pharmaceuticals (ETON) has 8 years of Change in Cash data on file, last reported at -$11.2 million in Q4 2025.

• For the quarter ending Q4 2025, Change in Cash fell 109.93% year-over-year to -$11.2 million; the trailing twelve-month figure through Dec 2025 stood at $11.0 million (up 270.58% YoY), and the FY2025 full-year result was $11.0 million, up 270.58% from the prior year.
• Change in Cash slipped to -$11.2 million in Q4 2025, from $11.7 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $11.7 million in Q3 2025 to a low of -$11.2 million in Q4 2025.
• A 5-year average of $232350.0 and a median of $756000.0 in 2021 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash soared 1319.33% in 2021 and sank 680.79% in 2024, its largest moves.
• Tracing ETON's Change in Cash over 5 years: stood at -$8.3 million in 2021, then surged by 135.25% to $2.9 million in 2022, then slumped by 123.3% to -$682000.0 in 2023, then slumped by 680.79% to -$5.3 million in 2024, then sank by 109.93% to -$11.2 million in 2025.
• Business Quant data shows ETON's Change in Cash at -$11.2 million in Q4 2025, $11.7 million in Q3 2025, and $8.0 million in Q2 2025.